Back
Kura Oncology Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
14
KURA
Kura Oncology
Last Price:
10.83
Seasonality Move:
19.26%
Buy
51
HALO
Halozyme Therapeutics
Last Price:
49.01
Seasonality Move:
17.34%
Sell
14
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
- The current Kura Oncology [KURA] share price is $10.80. The Score for KURA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- KURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
51
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $49.00. The Score for HALO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $10.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing slight buying pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $49.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
KURA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 21.77 | Sell |
| Chaikin Money Flow: | 2702856 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.7 - 18.64) | Sell |
| Bollinger Bands (100): | (17.12 - 21.06) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.25 | Sell |
| Relative Strength Index (14 RSI): | 43.09 | Sell |
| Chaikin Money Flow: | 3002123 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.05 - 58.35) | Sell |
| Bollinger Bands (100): | (51.29 - 60.61) | Sell |
KURA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.86 | Sell |
| 20-day SMA: | 16.47 | Sell |
| 50-day SMA: | 17.93 | Sell |
| 200-day SMA: | 19.94 | Sell |
| 8-day EMA: | 14.13 | Sell |
| 20-day EMA: | 15.9 | Sell |
| 50-day EMA: | 17.43 | Sell |
| 200-day EMA: | 18.29 | Sell |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.26 | Buy |
| 20-day SMA: | 53.24 | Sell |
| 50-day SMA: | 54.79 | Sell |
| 200-day SMA: | 49.21 | Sell |
| 8-day EMA: | 48.74 | Buy |
| 20-day EMA: | 51.64 | Sell |
| 50-day EMA: | 53.83 | Sell |
| 200-day EMA: | 50.48 | Sell |
Kura Oncology Earnings Growth & KURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.50 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Kura Oncology Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||